Clindamycin Hydrochloride
- Product NDC
- 70934-693
- 11-digit product format
- 709340693
- Labeler code
- 70934
- Product ID
- 70934-693_aa54fa9c-7e2b-8bab-e053-2995a90afaa7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clindamycin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA065243
- Marketing category
- ANDA
- Marketing start
- 2020-05-06
- Marketing end
- 0000-00-00
- Substance
- CLINDAMYCIN HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-693-30 | 70934069330 | 30 CAPSULE in 1 BOTTLE, PLASTIC (70934-693-30) | 30 capsule | 2020-05-06 | 0000-00-00 | No | No | Current |
| 70934-693-40 | 70934069340 | 40 CAPSULE in 1 BOTTLE, PLASTIC (70934-693-40) | 40 capsule | 2020-05-26 | 0000-00-00 | No | No | Current |